Literature DB >> 9362480

Solution structure of the transforming growth factor beta-binding protein-like module, a domain associated with matrix fibrils.

X Yuan1, A K Downing, V Knott, P A Handford.   

Abstract

Here we describe the high resolution nuclear magnetic resonance (NMR) structure of a transforming growth factor beta (TGF-beta)-binding protein-like (TB) domain, which comes from human fibrillin-1, the protein defective in the Marfan syndrome (MFS). This domain is found in fibrillins and latent TGF-beta-binding proteins (LTBPs) which are localized to fibrillar structures in the extracellular matrix. The TB domain manifests a novel fold which is globular and comprises six antiparallel beta-strands and two alpha-helices. An unusual cysteine triplet conserved in the sequences of TB domains is localized to the hydrophobic core, at the C-terminus of an alpha-helix. The structure is stabilized by four disulfide bonds which pair in a 1-3, 2-6, 4-7, 5-8 pattern, two of which are solvent exposed. Analyses of MFS-causing mutations and the fibrillin-1 cell-binding RGD site provide the first clues to the surface specificity of TB domain interactions. Modelling of a homologous TB domain from LTBP-1 (residues 1018-1080) suggests that hydrophobic contacts may play a role in its interaction with the TGF-beta1 latency-associated peptide.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362480      PMCID: PMC1170270          DOI: 10.1093/emboj/16.22.6659

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  PROSITE: a dictionary of sites and patterns in proteins.

Authors:  A Bairoch
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

2.  Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders.

Authors:  A K Downing; V Knott; J M Werner; C M Cardy; I D Campbell; P A Handford
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

Review 3.  Structure and distribution of modules in extracellular proteins.

Authors:  P Bork; A K Downing; B Kieffer; I D Campbell
Journal:  Q Rev Biophys       Date:  1996-05       Impact factor: 5.318

4.  Protein multiple sequence alignment and flexible pattern matching.

Authors:  G J Barton
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  Fibrillin: monomers and microfibrils.

Authors:  L Y Sakai; D R Keene
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities.

Authors:  M Nilges
Journal:  J Mol Biol       Date:  1995-02-03       Impact factor: 5.469

7.  Identification of a cDNA for a human high-molecular-weight B-cell growth factor.

Authors:  J L Ambrus; J Pippin; A Joseph; C Xu; D Blumenthal; A Tamayo; K Claypool; D McCourt; A Srikiatchatochorn; R J Ford
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome.

Authors:  L Pereira; M D'Alessio; F Ramirez; J R Lynch; B Sykes; T Pangilinan; J Bonadio
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

9.  Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils.

Authors:  J Taipale; J Saharinen; K Hedman; J Keski-Oja
Journal:  J Histochem Cytochem       Date:  1996-08       Impact factor: 2.479

Review 10.  Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.

Authors:  H C Dietz; R E Pyeritz
Journal:  Hum Mol Genet       Date:  1995       Impact factor: 6.150

View more
  39 in total

Review 1.  Fibrillin: from microfibril assembly to biomechanical function.

Authors:  Cay M Kielty; Clair Baldock; David Lee; Matthew J Rock; Jane L Ashworth; C Adrian Shuttleworth
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-02-28       Impact factor: 6.237

2.  Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta.

Authors:  J Saharinen; J Keski-Oja
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

Review 3.  The pathogenesis of aortopathy in Marfan syndrome and related diseases.

Authors:  Jeffrey A Jones; John S Ikonomidis
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

4.  Fibrillin-containing microfibrils are key signal relay stations for cell function.

Authors:  Karina A Zeyer; Dieter P Reinhardt
Journal:  J Cell Commun Signal       Date:  2015-10-08       Impact factor: 5.782

Review 5.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

6.  Dissecting coherent vibrational spectra of small proteins into secondary structural elements by sensitivity analysis.

Authors:  Wei Zhuang; Darius Abramavicius; Shaul Mukamel
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-13       Impact factor: 11.205

Review 7.  Molecular pathogenesis and management strategies of ectopia lentis.

Authors:  A Chandra; D Charteris
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

Review 8.  LTBPs in biology and medicine: LTBP diseases.

Authors:  Daniel B Rifkin; William J Rifkin; Lior Zilberberg
Journal:  Matrix Biol       Date:  2017-12-05       Impact factor: 11.583

9.  Effects of proline cis-trans isomerization on TB domain secondary structure.

Authors:  X Yuan; J M Werner; V Knott; P A Handford; I D Campbell; K Downing
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

10.  Two novel FBN1 mutations associated with ectopia lentis and marfanoid habitus in two Chinese families.

Authors:  Liming Zhao; Ting Liang; Jianzhen Xu; Hui Lin; Dandan Li; Yanhua Qi
Journal:  Mol Vis       Date:  2009-04-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.